USFDA revokes emergency use status to two Covid antibody therapies"Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequ...
25 Jan, 2022, 11.54 AM IST
India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
07 Jan, 2022, 04.06 PM IST
Russian court rejects US firm's lawsuit over COVID-19 drug remdesivirThe Russian government late last year granted Russian drugmaker Pharmasyntez a compulsory licence for one year to manufacture the drug unde...
28 May, 2021, 11.40 PM IST
Delhi International Airport handles 100 COVID-19 relief flights in last monthThe country's busiest airport is the largest cargo hub airport of south Asia region, with two integrated cargo terminals having an annual h...
25 May, 2021, 01.50 PM IST
While Covid vaccines help curb the pandemic, researchers are working on an antiviral pillSeveral companies, including Pfizer, Roche and AstraZeneca, are testing antivirals in pill form.
27 Apr, 2021, 06.07 PM IST
Gilead announces steps to expand availability of remdesivir in IndiaRemdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and ...
27 Apr, 2021, 08.28 AM IST
No lockdown in Maharashtra, Section 144 will kick in from tomorrow for the next 15 days13 Apr, 2021, 09.39 PM IST
WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patientsOn Friday, a World Health Organisation guidelines panel advised against using the antiviral remdesivir for hospitalised patients, saying th...
21 Nov, 2020, 08.16 AM IST
WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivirThe WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight market and to...
05 Nov, 2020, 09.42 PM IST
DCGI rejects Dr Reddy's proposal seeking change in regulatory approval status for remdesivirDr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeki...
02 Nov, 2020, 06.24 PM IST
USFDA approves use of remdesivir to treat Covid-19 patients in hospitalsThe approval of Veklury (remdesivir) was supported by the agency’s analysis of data from three randomized, controlled clinical trials that ...
23 Oct, 2020, 09.53 AM IST
USFDA approves remdesivir, first drug to treat COVID-19 patientsAccording to the press release by the company, previously authorised by the FDA for only emergency use to treat COVID-19 patients, Veklury ...
23 Oct, 2020, 09.39 AM IST
India to review use of remdesivir, hydroxychloroquine for Covid therapyIndian Council of Medical Research (ICMR) director general Balram Bhargava told ET that clinical protocols will be updated after discussion...
17 Oct, 2020, 08.12 AM IST
Gilead won't launch its Covid drug in JulyGilead has issued licences to nine generic drug companies to make and sell remdesivir. Six of the companies are Indian - Hetero, Cipla, Dr ...
03 Jul, 2020, 07.26 AM IST
Gilead's remdesivir set to become Europe's first COVID-19 therapyThe EMA endorsement means physicians can prescribe the Gilead drug in Europe once the European Commission, the EU executive, gives its appr...
25 Jun, 2020, 09.11 PM IST
DCGI gives nod to Hetero Labs and Cipla to manufacture and market remdesivirThe emergency approval is given to an unapproved therapy for compassionate use provided drug companies share the clinical data of the drug ...
20 Jun, 2020, 11.38 PM IST
Indian licensees free to price Remdesivir: GileadUS drug maker to launch own brand of Covid-19 experimental drug in the country next month. Gilead has licensed the drug to four companies —...
04 Jun, 2020, 10.22 PM IST